Basilea Pharmaceutica AG Share Price
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe Europe
12:40:36 01/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 63.65 CHF | +0.24% |
|
-1.85% | +16.09% |
| 19/08 | Basilea Pharmaceutica Ag Raises Earnings Guidance for the Full Year 2026 | CI |
| 18/08 | Swiss Market Index Closes Higher; Huber+Suhner Shares Drop | MT |
| Market Cap | 79Cr 97Cr 84Cr 72Cr 135.06Cr 9.27TCr 136.03Cr 933.27Cr 363.11Cr 4.7TCr 365.78Cr 357.83Cr 16TCr | P/E 2026 * |
18.7x | P/E 2027 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 64Cr 79Cr 68Cr 58Cr 109.32Cr 7.5TCr 110.11Cr 755.44Cr 293.92Cr 3.8TCr 296.08Cr 289.65Cr 13TCr | EV / Sales 2026 * |
2.45x | EV / Sales 2027 * | 2.12x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Basilea Pharmaceutica AG
| 1 day | +0.31% | ||
| 1 week | -1.85% | ||
| Current month | +22.35% | ||
| 1 month | +22.35% | ||
| 3 months | +26.49% | ||
| 6 months | +18.47% | ||
| Current year | +16.09% |
| 1 week | 62.6 |  | 66.5 |
| 1 month | 50.4 | | 66.5 |
| Current year | 47.8 | | 66.5 |
| 1 year | 44.7 | | 66.5 |
| 3 years | 32 | | 66.5 |
| 5 years | 29.55 | | 66.5 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/05/26 | Sell | -400 | 0.0030% | |||
| 13/05/26 | Sell | -1,043 | 0.0078% | |||
| 04/05/26 | Sell | 400 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.24% | -1.85% | +35.54% | +31.61% | 97Cr | |
| +0.02% | -1.91% | +0.98% | +17.94% | 4.98TCr | |
| -1.11% | -2.84% | +420.04% | +505.15% | 4.41TCr | |
| -0.21% | +0.37% | +36.88% | +17.32% | 4.3TCr | |
| -1.95% | -3.33% | +8.29% | +73.25% | 4.09TCr | |
| -0.94% | -1.77% | +18.34% | +46.84% | 3.31TCr | |
| -1.11% | -4.20% | +25.49% | +119.78% | 1.66TCr | |
| +6.10% | +4.40% | - | - | 1.73TCr | |
| +0.28% | -1.92% | +11.82% | +28.28% | 1.46TCr | |
| -1.12% | -3.46% | +76.50% | +39.37% | 1.38TCr | |
| Average | +0.02% | -1.42% | +70.43% | +97.73% | 2.74TCr | |
| Weighted average by Cap. | -0.34% | -1.50% | +88.67% | +122.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26Cr 32Cr 28Cr 24Cr 45Cr 3.07TCr 45Cr 308.86Cr 120.17Cr 1.56TCr 121.05Cr 118.42Cr 5.15TCr | 27Cr 33Cr 29Cr 25Cr 46Cr 3.18TCr 47Cr 320.56Cr 124.72Cr 1.61TCr 125.64Cr 122.91Cr 5.35TCr |
| Net income | 5.36Cr 6.62Cr 5.7Cr 4.89Cr 9.18Cr 630.33Cr 9.25Cr 63Cr 25Cr 319.63Cr 25Cr 24Cr 1.06TCr | 4.44Cr 5.5Cr 4.73Cr 4.06Cr 7.62Cr 522.92Cr 7.67Cr 53Cr 20Cr 265.16Cr 21Cr 20Cr 877.98Cr |
| Net Debt | -15Cr -19Cr -16Cr -14Cr -26Cr -1.77TCr -26Cr -177.83Cr -69Cr -895.65Cr -70Cr -68Cr -2.97TCr | -21Cr -26Cr -23Cr -20Cr -37Cr -2.51TCr -37Cr -253.21Cr -99Cr -1.28TCr -99Cr -97Cr -4.22TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | CHF 63.50 | -1.55% | 45,150 |
| 28/26/28 | CHF 64.50 | -1.38% | 29,170 |
| 27/26/27 | CHF 65.40 | -0.15% | 42,086 |
| 26/26/26 | CHF 65.50 | +0.31% | 48,673 |
| 25/26/25 | CHF 65.30 | +0.93% | 46,885 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
